FLAIR™ Delivery System Study

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05536310` - TAVIS Registry - Trilogy Heart Valve System for Management of Patients With Aortic Valve Disease
Recruiting	`NCT05817747` - Strategic Use of Big Data in Spine Surgery - Testing Digital Prediction of Outcome in Clinical Praxis	N/A
Completed	`NCT01343667` - GORE Flow Reversal System and GORE Embolic Filter Extension Study	N/A
Terminated	`NCT00004728` - Aspirin Or Warfarin To Prevent Stroke	Phase 3

See also

Status

Clinical Trial

Phase

Not yet recruiting

NCT05536310 - TAVIS Registry - Trilogy Heart Valve System for Management of Patients With Aortic Valve Disease

Recruiting

NCT05817747 - Strategic Use of Big Data in Spine Surgery - Testing Digital Prediction of Outcome in Clinical Praxis

N/A

Completed

NCT01343667 - GORE Flow Reversal System and GORE Embolic Filter Extension Study

N/A

Terminated

NCT00004728 - Aspirin Or Warfarin To Prevent Stroke

Phase 3

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT00614315
Study type	Interventional
Source	C. R. Bard
Contact
Status	Completed
Phase	N/A
Start date	December 2007
Completion date	February 2008

FLAIR™ Delivery System Study — FLAIR DS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms